<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="http://feeds.feedburner.com/~d/styles/rss2full.xsl" type="text/xsl" media="screen"?><?xml-stylesheet href="http://feeds.feedburner.com/~d/styles/itemcontent.css" type="text/css" media="screen"?><rss xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0"><channel><title>Pharma's Cutting Edge</title><link>http://www.pharmaweblog.com</link><description>Pharmaceutical and biotech science and business</description><language>en</language><lastBuildDate>Tue, 06 Jan 2009 08:37:35 -0600</lastBuildDate><thespringbox:skin xmlns:thespringbox="http://www.thespringbox.com/dtds/thespringbox-1.0.dtd">http://feeds.feedburner.com/PharmasCuttingEdgePosts?format=skin</thespringbox:skin><feedburner:awareness>http://api.feedburner.com/awareness/1.0/GetFeedData?uri=PharmasCuttingEdgePosts</feedburner:awareness><image><link>http://www.feedburner.com</link><url>http://www.feedburner.com/fb/images/pub/fb_pwrd.gif</url><title>This Feed Powered by FeedBurner.com</title></image><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" href="http://feeds.feedburner.com/PharmasCuttingEdgePosts" type="application/rss+xml" /><feedburner:browserFriendly>This is an XML content feed. It is intended to be viewed in a newsreader or syndicated to another site, subject to copyright and fair use.</feedburner:browserFriendly><item><title>Promising drug tech in 2009</title><link>http://www.pharmaweblog.com/2009/01/02/promising-drug-tech-in-2009/</link><description>I indicated in my year-end 2008 post that I was looking forward to a productive 2009 for the pharmaceutical/biopharmaceutical industry.  Indeed, there's a good chance that the number of approved new molecular entities in 2009 in Europe and the US will be noticeably more than in the last several years.

I've selected ...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~f/PharmasCuttingEdgePosts?a=j1PWBX.P"&gt;&lt;img src="http://feeds.feedburner.com/~f/PharmasCuttingEdgePosts?i=j1PWBX.P" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~f/PharmasCuttingEdgePosts?a=eVHyf9.P"&gt;&lt;img src="http://feeds.feedburner.com/~f/PharmasCuttingEdgePosts?i=eVHyf9.P" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~f/PharmasCuttingEdgePosts?a=vo0qks.P"&gt;&lt;img src="http://feeds.feedburner.com/~f/PharmasCuttingEdgePosts?i=vo0qks.P" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~f/PharmasCuttingEdgePosts?a=SNbJpX.p"&gt;&lt;img src="http://feeds.feedburner.com/~f/PharmasCuttingEdgePosts?i=SNbJpX.p" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description></item><item><title>Top drug innovations: 2008 edition</title><link>http://www.pharmaweblog.com/2008/12/16/top-drug-innovations-2008-edition/</link><description>In what has become an annual tradition, I give you my totally subjective choices for the top drug innovations of 2008.  In order to qualify the innovation must have been first available for salein the US or EU during 2008.  Sadly, it's slim pickins again this year, with only seven finalists, ...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~f/PharmasCuttingEdgePosts?a=nzCfhC.P"&gt;&lt;img src="http://feeds.feedburner.com/~f/PharmasCuttingEdgePosts?i=nzCfhC.P" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~f/PharmasCuttingEdgePosts?a=JJZqUI.P"&gt;&lt;img src="http://feeds.feedburner.com/~f/PharmasCuttingEdgePosts?i=JJZqUI.P" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~f/PharmasCuttingEdgePosts?a=wZ8ZpL.P"&gt;&lt;img src="http://feeds.feedburner.com/~f/PharmasCuttingEdgePosts?i=wZ8ZpL.P" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~f/PharmasCuttingEdgePosts?a=GKtWTP.p"&gt;&lt;img src="http://feeds.feedburner.com/~f/PharmasCuttingEdgePosts?i=GKtWTP.p" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description></item><item><title>DTC is the root of all evil?</title><link>http://www.pharmaweblog.com/2008/12/05/dtc-is-the-root-of-all-evil/</link><description>According to the Pharma Marketing Blog, which gets its data from MEd Ad News and Nielsen, the industry spent over $5 billion USD globally in 2007 on DTC advertising (IMS Health pegs it at just under $5 Billlion).  The US is the major portion of this spend.  IMS Health puts the ...&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~f/PharmasCuttingEdgePosts?a=7Wfde4.P"&gt;&lt;img src="http://feeds.feedburner.com/~f/PharmasCuttingEdgePosts?i=7Wfde4.P" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~f/PharmasCuttingEdgePosts?a=vbqXFt.P"&gt;&lt;img src="http://feeds.feedburner.com/~f/PharmasCuttingEdgePosts?i=vbqXFt.P" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~f/PharmasCuttingEdgePosts?a=jJrGEU.P"&gt;&lt;img src="http://feeds.feedburner.com/~f/PharmasCuttingEdgePosts?i=jJrGEU.P" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~f/PharmasCuttingEdgePosts?a=6WFVLk.p"&gt;&lt;img src="http://feeds.feedburner.com/~f/PharmasCuttingEdgePosts?i=6WFVLk.p" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;</description></item></channel></rss>
